Quantitative Investment Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Quantitative Investment Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-111,719	Closed	-$14.3M	–	541
2026 Q1	$14.3M	Buy	+111,719	New	+$13.9M	1.48%	7
2024 Q3	–	Sell	-15,683	Closed	-$1.45M	–	459
2024 Q2	$1.45M	Buy	+15,683	New	+$1.41M	0.16%	122
2023 Q3	–	Sell	-128,653	Closed	-$10.7M	–	354
2023 Q2	$10.7M	Buy	+128,653	New	+$10.8M	1.01%	25
2022 Q4	–	Sell	-210,670	Closed	-$16.7M	–	345
2022 Q3	$16.7M	Sell	210,670 -106,692	-34%	-$8.99M	2.77%	5
2022 Q2	$23.6M	Buy	+317,362	New	+$23.8M	3.59%	5
2021 Q2	–	Sell	-162,385	Closed	-$22M	–	623
2021 Q1	$22M	Buy	+162,385	New	+$24.3M	1.86%	7
2019 Q1	–	Sell	-148,300	Closed	-$10.6M	–	856
2018 Q4	$10.6M	Buy	148,300 +118,100	+391%	+$9.52M	0.55%	35
2018 Q3	$2.9M	Sell	30,200 -419,000	-93%	-$40.6M	0.1%	150
2018 Q2	$42.8M	Buy	+449,200	New	+$41.3M	0.88%	16
2017 Q4	–	Sell	-684,700	Closed	-$59.3M	–	899
2017 Q3	$59.3M	Sell	684,700 -767,298	-53%	-$61.5M	0.68%	18
2017 Q2	$112M	Buy	1,451,998 +1,256,398	+642%	+$89.1M	1.69%	5
2017 Q1	$13.6M	Buy	+195,600	New	+$13.1M	0.21%	117
2016 Q4	–	Sell	-107,500	Closed	-$7.13M	–	982
2016 Q3	$7.13M	Buy	+107,500	New	+$6.65M	0.24%	96
2016 Q1	–	Sell	-16,300	Closed	-$1.14M	–	968
2015 Q4	$1.14M	Sell	16,300 -176,200	-92%	-$12M	0.07%	335
2015 Q3	$12M	Buy	+192,500	New	+$15.2M	0.9%	17
2014 Q4	–	Sell	-8,400	Closed	-$436K	–	599
2014 Q3	$436K	Buy	+8,400	New	+$428K	0.08%	197
2014 Q2	–	Sell	-270,300	Closed	-$12.8M	–	657
2014 Q1	$12.8M	Buy	+270,300	New	+$13.8M	0.61%	27

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Quantitative Investment Management's XBI Position: Q2 2026 in Review

Quantitative Investment Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2026, closing a stake of 111,719 shares — an estimated $14.3M sold.

Quantitative Investment Management first reported a position in XBI in Q1 2014 and held it in 17 quarters. The position peaked at $112M in Q2 2017. 932 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Quantitative Investment Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2026 after selling out during the quarter.
Quantitative Investment Management sold 111,719 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $14.3M.
Quantitative Investment Management first reported a position in State Street SPDR S&P Biotech ETF in Q1 2014 and held it in 17 quarters.
Quantitative Investment Management's State Street SPDR S&P Biotech ETF position peaked at $112M in Q2 2017.
932 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Quantitative Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.